Tetherex Pharmaceuticals is Drug Discovery in United States that focus on in-class therapeutics business. Founded in 2002. They cover business area such as producer, thrombosis, inflammation, tumor metastasis, class, thrombotic, inflammatory, and oncologic disease, cell adhesion, patient, these affliction, descent and long life.
2002
( 22 years old in 2024 )
In-class Therapeutics
-
840 Research Parkway
Suite 516
Oklahoma City, OK 73104
United States
Private
producerthrombosisinflammationtumor metastasisclassthrombotic, inflammatory, and oncologic diseasecell adhesionpatientthese afflictiondescent and long life
* We use standard office opening hours in near Tetherex Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Tetherex Pharmaceuticals is Drug Discovery business from United States that founded in 2002 (22 years old in 2024), Tetherex Pharmaceuticals business is focusing on In-class Therapeutics.
Tetherex Pharmaceuticals headquarter office and corporate office address is located in 840 Research Parkway Suite 516 Oklahoma City, OK 73104 United States.
Tetherex Pharmaceuticals was founded in United States.
In 2024, Tetherex Pharmaceuticals is currently focus on in-class therapeutics sector.
Above is snippet of Google Trends for "in-class therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Tetherex Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
